| NCT04691154 | A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD | ACTIVE_NOT_RECRUITING | PHASE3 | 2021-08-01 | 2025-07-31 | 2024-06-30 |
| NCT03884465 | Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil | TERMINATED | PHASE2 | 2019-11-11 | 2020-12-23 | 2020-12-23 |
| NCT03992755 | Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil | ACTIVE_NOT_RECRUITING | PHASE3 | 2019-07-18 | 2025-05-31 | 2025-05-31 |
| NCT03399604 | Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil | COMPLETED | PHASE3 | 2018-01-02 | 2019-11-25 | 2019-05-06 |
| NCT02982889 | Single Ascending Dose Study of Two Liquidia Bupivacaine Formulations | COMPLETED | PHASE1 | 2016-12-05 | 2017-04-26 | 2017-03-23 |
| NCT01224262 | A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 | COMPLETED | PHASE1, PHASE2 | 2010-09 | 2011-12 | 2011-12 |